• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格列齐特-聚乙二醇固体分散体的理化性质表征及基于优化分散体的片剂

Physicochemical characterization of gliclazide-macrogol solid dispersion and tablets based on optimized dispersion.

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Kuwait University, Safat, Kuwait.

出版信息

Drug Dev Ind Pharm. 2010 Aug;36(8):893-902. doi: 10.3109/03639040903578734.

DOI:10.3109/03639040903578734
PMID:20196643
Abstract

BACKGROUND

This study investigated the physical interaction of gliclazide (GLC) with a hydrophilic carrier, that is, macrogol [polyethylene glycol (PEG)]. Different molecular weights of PEG (4000, 10,000, and 20,000) were used in different drug : carrier weight ratios (1 : 1, 1 : 2, 1 : 5, and 1 : 10).

METHOD

Preliminary screening was done by phase solubility studies to characterize the liquid state interaction between the drug and the carrier. Solid dispersions (SDs) of GLC and PEG in different ratios were prepared by fusion technique and by physical mixing. The solid-state interaction between the drug and the carrier was examined by performing differential scanning calorimetry and Fourier transform infrared spectroscopic studies. SD with satisfactory characteristics was selected for the formulation of tablets by wet granulation method and compared with the commercial brand for in vitro dissolution.

RESULTS

It was evident from phase solubility studies that the drug solubility increased linearly with increasing PEG concentrations. In vitro dissolution of GLC improved significantly in the SDs prepared by fusion method as compared with the original drug and physical mixtures. Scanning electron microscopy images showed well-defined changes in the surface topography of GLC, thus confirming the effective formation of a fused binary system. The SD tablets showed a significant improvement in the drug release profile than that of the commercial brand.

CONCLUSION

It was thus concluded that SD formulations of GLC can be successfully used to design a solid dosage form of the drug, which would have significant advantages over the current marketed tablets.

摘要

背景

本研究调查了格列齐特(GLC)与亲水性载体,即聚乙二醇(PEG)的物理相互作用。不同分子量的 PEG(4000、10000 和 20000)以不同的药物:载体重量比(1:1、1:2、1:5 和 1:10)用于研究。

方法

通过相溶解度研究进行初步筛选,以表征药物与载体之间的液态相互作用。通过熔融技术和物理混合制备 GLC 和 PEG 以不同比例的固体分散体(SD)。通过差示扫描量热法和傅里叶变换红外光谱研究检查药物与载体之间的固态相互作用。选择具有满意特性的 SD 通过湿法制粒法制备片剂,并与市售品牌进行体外溶出度比较。

结果

相溶解度研究表明,药物溶解度随 PEG 浓度的增加呈线性增加。与原药和物理混合物相比,熔融法制备的 SD 中 GLC 的体外溶出度显著提高。扫描电子显微镜图像显示 GLC 的表面形貌发生了明显变化,从而证实了熔融二元体系的有效形成。SD 片剂的药物释放曲线明显优于市售品牌。

结论

因此,可以得出结论,GLC 的 SD 制剂可成功用于设计该药物的固体制剂,这将比当前市售片剂具有显著优势。

相似文献

1
Physicochemical characterization of gliclazide-macrogol solid dispersion and tablets based on optimized dispersion.格列齐特-聚乙二醇固体分散体的理化性质表征及基于优化分散体的片剂
Drug Dev Ind Pharm. 2010 Aug;36(8):893-902. doi: 10.3109/03639040903578734.
2
Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.格列齐特-聚乙二醇4000固体分散体的制备与表征
Acta Pharm. 2009 Mar;59(1):57-65. doi: 10.2478/v10007-009-0001-3.
3
In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000.格列齐特:聚乙二醇6000固体分散体系统的体内和体外评价
PDA J Pharm Sci Technol. 2007 Sep-Oct;61(5):400-10.
4
Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.泼尼松:聚乙二醇6000速释片固体分散体的研制:固态表征、溶出行为及处方参数
AAPS PharmSciTech. 2007 Dec 14;8(4):E108. doi: 10.1208/pt0804108.
5
Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000.使用聚乙二醇6000固体分散体提高格列齐特的溶出速率。
AAPS PharmSciTech. 2008;9(2):563-70. doi: 10.1208/s12249-008-9079-z. Epub 2008 May 6.
6
Effect of two hydrophobic polymers on the release of gliclazide from their matrix tablets.两种疏水性聚合物对格列齐特从其骨架片中释放的影响。
Acta Pol Pharm. 2013 Jul-Aug;70(4):749-57.
7
Physicochemical characterization of artemether solid dispersions with hydrophilic carriers by freeze dried and melt methods.水载体的冻干粉化和热熔法制备蒿甲醚固体分散体的理化特性研究。
Arch Pharm Res. 2010 Jun;33(6):901-10. doi: 10.1007/s12272-010-0613-7. Epub 2010 Jul 6.
8
Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.罗非昔布-聚乙二醇4000固体分散体及基于固体分散体的片剂的特性
Pharm Dev Technol. 2005;10(4):467-77. doi: 10.1080/10837450500299701.
9
Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.使用基于亲水性载体的高效固体分散体系统提高胡椒碱的溶解度。
Drug Dev Ind Pharm. 2017 Sep;43(9):1501-1509. doi: 10.1080/03639045.2017.1321658. Epub 2017 May 5.
10
A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.一种新型非对称膜渗透泵胶囊,具有原位形成的释药孔,用于格列齐特固体分散体系统的控释。
Int J Pharm. 2016 Jun 15;506(1-2):340-50. doi: 10.1016/j.ijpharm.2016.04.061. Epub 2016 Apr 27.

引用本文的文献

1
Physicochemical reports of gliclazide-carplex solid dispersions and tablets prepared with directly compressible co-processed excipients.使用直接压片共处理辅料制备的格列齐特-卡普列克斯固体分散体和片剂的物理化学报告。
Heliyon. 2023 Nov 26;9(12):e22899. doi: 10.1016/j.heliyon.2023.e22899. eCollection 2023 Dec.
2
Effect of Molecular Weight on the Dissolution Profiles of PEG Solid Dispersions Containing Ketoprofen.分子量对含酮洛芬聚乙二醇固体分散体溶出曲线的影响
Polymers (Basel). 2023 Mar 31;15(7):1758. doi: 10.3390/polym15071758.
3
Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension.
格列齐特纳米混悬液的药代动力学及抗糖尿病研究
Pharmaceutics. 2022 Sep 14;14(9):1947. doi: 10.3390/pharmaceutics14091947.
4
In vitro and in vivo Evaluation of Ibuprofen Nanosuspensions for Enhanced Oral Bioavailability.布洛芬纳米混悬剂口服生物利用度增强的体内外评价。
Med Princ Pract. 2021;30(4):361-368. doi: 10.1159/000516299. Epub 2021 Apr 6.
5
Mechanistic insights into acyclovir-polyethylene glycol 20000 binary dispersions.阿昔洛韦-聚乙二醇20000二元分散体的作用机制洞察
Int J Pharm Investig. 2016 Oct-Dec;6(4):194-200. doi: 10.4103/2230-973X.195925.
6
Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems.通过固体分散体系统进行依非韦伦的制剂开发及溶出速率提高
Indian J Pharm Sci. 2013 May;75(3):291-301. doi: 10.4103/0250-474X.117434.